Literature DB >> 16824121

The rationale for the IL-2-independent generation of the self-renewing central memory CD8+ T cells.

Douglas T Fearon1, James M Carr, Aino Telaranta, Marlene J Carrasco, James E D Thaventhiran.   

Abstract

Clones of CD8+ T cells that have been selected in the primary response must have a mechanism by which they can continuously or intermittently generate new effector cells. Several years ago, this mechanism was proposed to involve a self-renewing, stem cell-like subset that could avoid the differentiating effects of interleukin-2 (IL-2). The model considered the stem cell subset to be contained within the central memory population of CD8+ T cells (T(CM)). This proposal was inconsistent with subsequent findings suggesting that all antigen-activated CD8+ T cells differentiated to effector cells (T(EFF)) during the primary response and that T(CM) developed during the memory phase by de-differentiating from effector memory cells (T(EM)). However, findings have since been reported that support the stem cell model. First, studies indicate that T(EM) do not serve as the precursors of T(CM). Second, transcriptional repressors of IL-2 signaling do enhance the memory response. Third, memory cells lacking effector functions and with a capacity to replicate in a secondary response develop in the absence of signaling through the IL-2/IL-15 receptor. Taken together, these findings suggest that antigen-activated CD8+ T cells with a stem cell-like capability for maintaining proliferative potential develop by an unknown IL-2-independent process. The challenge is now to identify this unknown pathway of clonal expansion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824121     DOI: 10.1111/j.0105-2896.2006.00390.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  14 in total

1.  Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto
Journal:  Clin Exp Immunol       Date:  2016-01-11       Impact factor: 4.330

2.  Coupled regulation of interleukin-12 receptor beta-1 of CD8+ central memory and CCR7-negative memory T cells in an early alloimmunity in liver transplant recipients.

Authors:  H Egawa; K Ozawa; Y Takada; S Teramukai; A Mori; K Ogawa; T Kaido; Y Fujimoto; Y Kawaguchi; E Hatano; H Sato; M Ono; K Takai; K Tanaka; S Uemoto
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

Review 3.  Human memory T cells: generation, compartmentalization and homeostasis.

Authors:  Donna L Farber; Naomi A Yudanin; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

4.  Inhibition of TGF-β1 signaling promotes central memory T cell differentiation.

Authors:  Shinji Takai; Jeffrey Schlom; Joanne Tucker; Kwong Y Tsang; John W Greiner
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

5.  Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients.

Authors:  Juhua Zhou; Prakash Nagarkatti; Yin Zhong; Mitzi Nagarkatti
Journal:  Anticancer Res       Date:  2011-12       Impact factor: 2.480

6.  CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation.

Authors:  James M Carr; Marlene J Carrasco; James E D Thaventhiran; Paul J Bambrough; Matthew Kraman; Alexander D Edwards; Aymen Al-Shamkhani; Douglas T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-11       Impact factor: 11.205

7.  Early coupled up-regulation of interleukin-12 receptor beta-1 in CD8+ central memory and effector T cells for better clinical outcomes in liver transplant recipients.

Authors:  S Uemoto; K Ozawa; T Kaido; A Mori; Y Fujimoto; K Ogawa
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

Review 8.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

9.  CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Authors:  Victor Peperzak; Yanling Xiao; Elise A M Veraar; Jannie Borst
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

10.  Increase in IFNγ(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza.

Authors:  Jason M Weaver; Hongmei Yang; David Roumanes; F Eun-Hyung Lee; Hulin Wu; John J Treanor; Tim R Mosmann
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.